#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Lymphatic malformation Myotonia Marginal zone lymphoma Pulmonary alveolar haemorrhage Glycogen storage disease type I Epstein-Barr virus infection Chordoma Herpes simplex Pleural mesothelioma Immune-mediated enterocolitis Chronic lymphocytic leukaemia recurrent Dermatitis Anaplastic large cell lymphoma T- and null-cell types Vascular malformation More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Trials in Disease Prader-Willi syndrome – Trials in Disease Hepatoblastoma – Life with Disease Splenic marginal zone lymphoma Nodal marginal zone B-cell lymphoma – Trials in Disease Synovial sarcoma recurrent – Treatment Mantle cell lymphoma refractory – Life with Disease Alagille syndrome Basal cell naevus syndrome Niemann-Pick disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propranolol Linerixibat Sodium Chloride Ph. Eur. Tedizolid Phosphate Fludarabine Phosphate Ng004 Avacincaptad Pegol L-METHIONINE INF904 Fusidic Acid Rhh646 Tipiracil Elebsiran Molidustat Sodium Dexketoprofen Tetracycline Hydrochloride Deferoxamine Mesilate Misoprostol Bms-986340 Sodium Gluconate More therapies…

    Learn about Your Condition

    Endometrial cancer metastatic HER2 positive gastric cancer Congenital pseudarthrosis Myocarditis Pulmonary vascular disorder Rectal cancer stage III Testicular germ cell cancer Osteopenia Coronary artery bypass Acute kidney injury Uterine leiomyosarcoma Skin wrinkling Tricuspid valve disease Vesicoureteric reflux Nocturia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous system disorder

  • Study on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ocrelizumab
    Bulgaria France Germany

  • Study on the Effects of Dexmedetomidine on Brain Fluid Flow and Activity in Patients with Neurodegenerative Diseases, Delirium, or Acute Neurological Conditions

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Delirium
    • Nervous system disorder
    • Neurodegenerative disorder
    Investigated Drugs:
    • Dexmedetomidine
    Finland

  • Study of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Nervous system disorder
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Kyv-101
    • Ublituximab
    • Ocrelizumab
    Austria Belgium Germany Italy

  • Continued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nervous system disorder
    Investigated Drugs:
    • Ocrelizumab
    • Dexamethasone Acetate
    • Lidocaine Hydrochloride Monohydrate
    Czechia France Germany

  • Study on the Effects of Cannabidiol on the Central Nervous System in Healthy Male Participants

    Not recruiting

    2 1
    Investigated Diseases:
    • Nervous system disorder
    Investigated Drugs:
    • Cannabidiol
    The Netherlands

  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Magnetic resonance imaging
    • Nervous system disorder
    Investigated Drugs:
    • Gadoquatrane
    • Gadoteridol
    • Gadoteric Acid
    Bulgaria Czechia France Germany Hungary Italy +1
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!